The Integrated Population (I-POP) Health Trial (I-POP)

February 10, 2026 updated by: Baylor Research Institute

The Role of Community Health Workers to Reduce Health Disparities Using a Multi-Level Integrated Population Health Intervention

The primary aim of this study is to determine whether community health worker (CHW) navigation improves outcomes of chronic disease and chronic disease risk factors in a low-income, primarily ethnic minority population when combined with an evidence-based population health model as compared to usual care after 10 months.

Study Overview

Detailed Description

The I-POP+CHW participants will be paired with a CHW at baseline to assist with navigation for 10-months between health and wellness services in the selected zip codes: 75210, 75215, 75216, 75217, 75223, or 75227. Participants will receive a multi-level intervention utilizing the current I-POP Health model that includes: 1) Access to health services (including oral health), 2) Access to clinical prevention services, 3) Access to education and facilities to increase physical activity and improved nutrition choices, and 4) Scheduled visits with CHWs for education and navigation. Individuals will complete study measures at baseline, 6-months, and 10-months.

The control group participants will receive access to the same I-POP Health resources without CHW navigation until the end of 10-months (delayed CHW navigation). The current usual care model is outlined below (section 2.3) Participants will complete study measures at baseline, 6-months, and 10-months timepoints. Upon completion of 10-months measures, these individuals will be assigned a CHW and receive delayed navigation.

Study Type

Interventional

Enrollment (Actual)

202

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Dallas, Texas, United States, 75210
        • Baylor Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18 years or older
  • Ability to alter diet and/or physical activity
  • Willing to participate in a 10-month study
  • Resident of selected zip codes: 75210, 75215, 75216, 75217, 75223, or 75227
  • Not having utilized BSW HWC membership services within the past 12 months
  • Not planning to move outside of the selected zip code area within the next 6 months

Exclusion Criteria:

  • Below the age of 18 years
  • Unable or unwilling to alter diet and/or physical activity
  • Not willing to participate in a 10-month study
  • Not resident of local selected zip codes: 75210, 75215, 75216, 75217, 75223, or 75227
  • Currently using or have used BSW HWC membership services within the past 12 months
  • Planning to move outside of the selected zip code area within the next 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control
Control group participants will receive access to the same I-POP Health resources without CHW navigation until the end of 10-months (delayed CHW navigation). The current usual care model is outlined. Participants will complete study measures at baseline, 6-months, and 10-months timepoints. Upon completion of 10-months measures, these individuals will be assigned a CHW and receive delayed navigation.
The current I-POP health model includes: 1) BSW HWC primary care medical home (for uninsured or Medicare patients), 2)BSW HWC providing diabetes prevention, nutrition education, weight loss, farm stands, physical activity programming (in collaboration with its onsite City of Dallas Park and Recreation Center), 3) BSW HWC programming at community sites in 75210, 4) Referrals to Parkland Hatcher Station clinic that provides health care to Medicaid patients, 5) Referrals between Parkland Hatcher Station and BSW HWC programming, 6) Community improvement in collaboration with Frazier Revitalization Inc. Individuals will have access to resources within our current, ongoing I-POP Health model, but without CHW navigation between BSW HWC and local service providers. Participants will complete follow-up visits for collection of study measures with study personnel at 6- and 10- months. At the end of the 10-month follow-up period, participants receive an assigned CHW and CHW-navigation.
Experimental: I-POP CHW Intervention
I-POP+CHW participants will be paired with a CHW at baseline to assist with navigation for 10-months between health and wellness services in the selected zip codes: 75210, 75215, 75216, 75217, 75223, or 75227. Participants will receive a multi-level intervention utilizing the current I-POP Health model that includes: 1) Access to health services (including oral health), 2) Access to clinical prevention services, 3) Access to education and facilities to increase physical activity and improved nutrition choices, and 4) Scheduled visits with CHWs for education and navigation. Individuals will complete study measures at baseline, 6-months, and 10-months.
Individuals randomized to this condition will be paired with a CHW to assist with navigation of I-POP Health resources at BSW HWC and entities in local zip codes. CHW navigation will occur through monthly one-on-one follow-up visits for a period of 10-months. Participants will complete study visits for collection of data measures at baseline, 6- and 10- month timepoints. Study participation ends with completion of 10-months data measures.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Allostatic load
Time Frame: Baseline
A composite score of 10 biomarkers to measure chronic stress and health outcomes. The biomarkers are BMI, waist-to-hip ratio, HDL, TC/HDL ratio, triglycerides, HbA1c, SBP, DBP, C-reactive protein, and cortisol. For each marker a value of 1 will be assigned if that exceed the third quartile except for HDL where a value of 1 will be assigned if lower than first quartile; otherwise a score of zero will be assigned. [scale: Count of risk factors. May be dichotomized as high risk = 6 to 10, low risk=0 to 5]
Baseline
Allostatic load
Time Frame: 6-months
A composite score of 10 biomarkers to measure chronic stress and health outcomes. The biomarkers are BMI, waist-to-hip ratio, HDL, TC/HDL ratio, triglycerides, HbA1c, SBP, DBP, C-reactive protein, and cortisol. For each marker a value of 1 will be assigned if that exceed the third quartile except for HDL where a value of 1 will be assigned if lower than first quartile; otherwise a score of zero will be assigned. [scale: Count of risk factors. May be dichotomized as high risk = 6 to 10, low risk=0 to 5].
6-months
Cortisol
Time Frame: Baseline
4mL saliva collected fasting in the morning. [Scale: measured in a continuous scale. Normal range 0.007 - 0.115 ug/dL. Value exceeded the normal range indicates higher level of stress.]
Baseline
Cortisol
Time Frame: 6-months
4mL saliva collected fasting in the morning. [Scale: measured in a continuous scale. Normal range 0.007 - 0.115 ug/dL. Value exceeded the normal range indicates higher level of stress.]
6-months
C-Reactive protein
Time Frame: Baseline
4mL saliva collected fasting in the morning. [Scale: measured in a continuous scale. Normal range 25 pg/mL - 1600 pg/mL. Value exceeded the normal range indicates higher level of inflammation.]
Baseline
C-Reactive protein
Time Frame: 6-months
4mL saliva collected fasting in the morning. [Scale: measured in a continuous scale. Normal range 25 pg/mL - 1600 pg/mL. Value exceeded the normal range indicates higher level of inflammation.]
6-months
Body mass index
Time Frame: Baseline
Weight in pounds (lbs) divided by height in inches (in) squared and multiplying by a conversion factor of 703
Baseline
Body mass index
Time Frame: 6-months
Weight in pounds (lbs) divided by height in inches (in) squared and multiplying by a conversion factor of 703
6-months
Body mass index
Time Frame: 10-months
Weight in pounds (lbs) divided by height in inches (in) squared and multiplying by a conversion factor of 703
10-months
Waist - to - Hip ratio
Time Frame: Baseline
Waist circumference (centimeters) divided by circumference of hips (centimeters)
Baseline
Waist - to - Hip ratio
Time Frame: 6-months
Waist circumference (centimeters) divided by circumference of hips (centimeters)
6-months
Waist - to - Hip ratio
Time Frame: 10-months
Waist circumference (centimeters) divided by circumference of hips (centimeters)
10-months
HbA1c
Time Frame: Baseline
Finger stick blood measure (%)
Baseline
HbA1c
Time Frame: 6-months
Finger stick blood measure (%)
6-months
HbA1c
Time Frame: 10-months
Finger stick blood measure (%)
10-months
Lipids
Time Frame: Baseline
Finger stick blood measure collected fasting via fingerstick (mg/dL)
Baseline
Lipids
Time Frame: 6-months
Finger stick blood measure collected fasting via fingerstick (mg/dL)
6-months
Lipids
Time Frame: 10-months
Finger stick blood measure collected fasting via fingerstick (mg/dL)
10-months
Blood pressure
Time Frame: Baseline
Stadiometer used to measure systolic and diastolic pressures to nearest 1 mm Hg
Baseline
Blood pressure
Time Frame: 6-months
Stadiometer used to measure systolic and diastolic pressures to nearest 1 mm Hg
6-months
Blood pressure
Time Frame: 10-months
Stadiometer used to measure systolic and diastolic pressures to nearest 1 mm Hg
10-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diet
Time Frame: Baseline
Measured by self report Dietary Screening questionnaire (DSQ). [scale: dietary nutrients will be calculated on a continuous scale based on NHANES guideline. Score: 0 to any positive value. A score above or below the threshold based on 2000 calories per day would indicate worse outcome.]
Baseline
Diet
Time Frame: 6-months
Measured by self report Dietary Screening questionnaire (DSQ). [scale: dietary nutrients will be calculated on a continuous scale based on NHANES guideline. Score: 0 to any positive value. A score above or below the threshold based on 2000 calories per day would indicate worse outcome.]
6-months
Diet
Time Frame: 10-months
Measured by self report Dietary Screening questionnaire (DSQ). [scale: dietary nutrients will be calculated on a continuous scale based on NHANES guideline. Score: 0 to any positive value. A score above or below the threshold based on 2000 calories per day would indicate worse outcome.]
10-months
Physical activity
Time Frame: Baseline
Measured by self report questionnaire [type, frequency, and time completed in minutes]
Baseline
Physical activity
Time Frame: 6-months
Measured by self report questionnaire [type, frequency, and time completed in minutes]
6-months
Physical activity
Time Frame: 10-months
Measured by self report questionnaire [type, frequency, and time completed in minutes]
10-months
Services utilization
Time Frame: Baseline
Measured by self-report survey. [scale: count the number visits at healthcare or wellness centers. A higher score would indicate better utilization.]
Baseline
Services utilization
Time Frame: 6-months
Measured by self-report survey. [scale: count the number visits at healthcare or wellness centers. A higher score would indicate better utilization.]
6-months
Services utilization
Time Frame: 10-months
Measured by self-report survey. [scale: count the number visits at healthcare or wellness centers. A higher score would indicate better utilization.]
10-months
Social determinants
Time Frame: Baseline
Measured by self-report survey
Baseline
Social determinants
Time Frame: 6-months
Measured by self-report survey
6-months
Social determinants
Time Frame: 10-months
Measured by self-report survey
10-months
Perceived stress
Time Frame: Baseline
Measured by Perceived Stress Scale (PSS-10) [scale: high risk=40, moderate risk=20, low risk=0]
Baseline
Perceived stress
Time Frame: 6-months
Measured by Perceived Stress Scale (PSS-10) [scale: high risk=40, moderate risk=20, low risk=0]
6-months
Perceived stress
Time Frame: 10-months
Measured by Perceived Stress Scale (PSS-10) [scale: high risk=40, moderate risk=20, low risk=0]
10-months
Medication use
Time Frame: Baseline
Measured by self-report survey
Baseline
Medication use
Time Frame: 6-months
Measured by self-report survey
6-months
Medication use
Time Frame: 10-months
Measured by self-report survey
10-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heather Kitzman, PhD, Baylor Scott and White Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2021

Primary Completion (Actual)

May 18, 2023

Study Completion (Actual)

May 18, 2025

Study Registration Dates

First Submitted

January 28, 2021

First Submitted That Met QC Criteria

February 17, 2021

First Posted (Actual)

February 18, 2021

Study Record Updates

Last Update Posted (Actual)

February 12, 2026

Last Update Submitted That Met QC Criteria

February 10, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD that underlie results in a publication

IPD Sharing Time Frame

Within 6 months of study completion

IPD Sharing Access Criteria

Available by contacting study PI or reading publication

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Usual Care

Subscribe